The importance of data governance in pharma’s AI integration. This and more in this week’s life sciences update. … READ MORE >
biopharma
5 things to know in life sciences: Week of Feb. 24, 2025
The biopharma sector reported strong fourth quarter earnings. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of Feb. 17, 2025
Biotech CEOs discuss the highs and lows of a successful IPO. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Feb. 10, 2025
Large pharmaceutical companies are turning to AI more frequently, despite some challenges. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of Feb. 3, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Jan. 27, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Jan. 13, 2025
J.P. Morgan Healthcare Conference highlights and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Jan. 6, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Dec. 16, 2024
Manufacturing takes center stage in biopharma. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of December 9, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. FTC appointments possibly signal decreased scrutiny on biopharma M&A President-elect Donald Trump’s nomination of Andrew Ferguson and Mark Meador to the Federal Trade Commission signals a potential shift toward a more business-friendly antitrust approach, focusing on … … READ MORE >